| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| docetaxel prostate cancer | 0.4 | 0.6 | 2762 | 25 | 25 |
| docetaxel | 1.03 | 0.3 | 6984 | 7 | 9 |
| prostate | 0.89 | 0.2 | 362 | 7 | 8 |
| cancer | 1.97 | 0.7 | 9156 | 39 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| docetaxel prostate cancer | 1.04 | 0.5 | 4744 | 82 |
| docetaxel prostate cancer life expectancy | 1.28 | 0.4 | 8954 | 69 |
| docetaxel prostate cancer protocol | 0.19 | 0.4 | 2949 | 97 |
| docetaxel prostate cancer survival rates | 1.42 | 0.5 | 3062 | 24 |
| docetaxel prostate cancer dose | 1.9 | 0.5 | 7176 | 35 |
| docetaxel prostate cancer nejm | 0.19 | 0.9 | 5365 | 78 |
| docetaxel prostate cancer regimen | 1.82 | 0.2 | 1026 | 41 |
| docetaxel prostate cancer survival | 1.61 | 0.7 | 8414 | 6 |
| docetaxel prostate cancer uptodate | 1.6 | 0.4 | 1141 | 90 |
| docetaxel prostate cancer metastatic | 0.9 | 0.8 | 7183 | 35 |
| docetaxel prostate cancer side effects | 1.11 | 0.4 | 1274 | 99 |
| docetaxel prostate cancer clinical trial | 1.99 | 0.7 | 989 | 57 |
| docetaxel chemotherapy for prostate cancer | 1.69 | 0.9 | 7637 | 70 |
| docetaxel prednisone prostate cancer | 1.81 | 0.8 | 6124 | 80 |
